Biotechnology FDA Generic Drugs Health Law Policy History Intellectual Property Jonathan Darrow Pharmaceuticals The Rise of Biosimilars: Success of the BPCIA? (Part I) Read more: The Rise of Biosimilars: Success of the BPCIA? (Part I)
Health Law Policy Holly Fernandez Lynch Public Health What Should Academics Know About Lobbying Law? Read more: What Should Academics Know About Lobbying Law?
Health Care Reform Health Law Policy John Tingle Medical Quality Medical Safety Patient Care Petrie-Flom Center Public Health Improving the Mindset on NHS Complaint Handling Read more: Improving the Mindset on NHS Complaint Handling
Aaron S. Kesselheim Addiction Ameet Sarpatwari Charlie Lee FDA Frazer Tessema Generic Drugs Global Health Health Law Policy Medicare/Medicaid Opioid Crisis Pharmaceuticals Monthly Round-Up of What to Read on Pharma Law and Policy Read more: Monthly Round-Up of What to Read on Pharma Law and Policy
Announcements Behavioral Economics Biotechnology Call for Applications Jessica Sagers Pharmaceuticals What’s Missing From Biotech Graduate Education? With Free Course, RA Capital Attempts to Fill the Gaps Read more: What’s Missing From Biotech Graduate Education? With Free Course, RA Capital Attempts to Fill the Gaps
Bioethics Disability Genetics GINA Series Kaitlyn Dowling Uncertainty and Immutability: Arguments for Genetic Nondiscrimination Read more: Uncertainty and Immutability: Arguments for Genetic Nondiscrimination
2020 Election 8th Annual Health Law Year in P/Review Global Health Health Law Policy Human Rights Immigration Immunization Influenza Population-Level Bioethics Public Health Social Determinants of Health Wendy Parmet Targeting Health: How Anti-Immigrant Policies Threaten Our Health & Our Humanity Read more: Targeting Health: How Anti-Immigrant Policies Threaten Our Health & Our Humanity
Health Care Finance Health Law Policy Pharmaceuticals Recent Litigation Developments Regarding Drug Pricing and Access Read more: Recent Litigation Developments Regarding Drug Pricing and Access